Miguel Gonzalez Velez, Thoracic Oncologist, Drug Discovery, Hematology Oncology Fellow shared a post on LinkedIn:
“Congratulations to Peters Solange and colleagues on the CORRELATE RWE data on NSCLC.
We see this all the time in clinic. Even patients that meet trials criteria tend to do worse. One of the hardest conversations is to convey in easy and realistic way a very nuanced answer to patients and families.”
Title: Real-world outcomes versus clinical trial results of first-line immunotherapy with or without chemotherapy in patients with metastatic non-small-cell lung cancer: the CORRELATE study
Authors: S. Peters, R.J.-B. Salomonsen, I. Diaz Perez, T. Shcherbakova, A. Wang, L. Cai, S. Sadow, S. V. Liu
Read The Full Article
